52
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Cardiovascular risk factor control is insufficient in young patients with coronary artery disease

, , , &
Pages 219-227 | Published online: 25 May 2016

References

  • SchoenenbergerAWRadovanovicDStaufferJ-CAMIS Plus Investigators. Acute coronary syndromes in young patients: presentation, treatment and outcomeInt J Cardiol201114830030419942306
  • ReibisRTreszlAWegscheiderKBestehornKKarmannBVöllerHDisparity in risk factor pattern in premature versus late-onset coronary artery disease: a survey of 15,381 patientsVasc Health Risk Manag2012847348122930639
  • RisgaardBWinkelBGJabbariRBurden of sudden cardiac death in persons aged 1 to 49 years: nationwide study in DenmarkCirc Arrhythm Electrophysiol2014720521124604905
  • KhawajaFJRihalCSLennonRJHolmesDRPrasadATemporal trends (over 30 years), clinical characteristics, outcomes, and gender in patients ≤50 years of age having percutaneous coronary interventionAm J Cardiol201110766867421247541
  • PerkJDe BackerGGohlkeHEuropean Association for Cardiovascular Prevention & Rehabilitation (EACPR), ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)Eur Heart J2012331635170122555213
  • PaixaoARMEnriquezJRWangTYRisk factor burden and control at the time of admission in patients with acute myocardial infarction: results from the NCDRAm Heart J2015170173179.e126093879
  • KotsevaKWoodDDe BacquerDEUROASPIRE InvestigatorsEUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countriesEur J Prev Cardiol201623663664825687109
  • The Danish National Institute of Public HealthThe Danish Health and Morbidity Survey 2005 [Internet]2006 cited October 23, 2015172 Available from: http://si-folkesundhed.dk/upload/personligt_interviews-kema_med_svarfordeling_-_2005.pdfAccessed October 23, 2015
  • MyersMGGodwinMDawesMKissATobeSWKaczorowskiJConventional versus automated measurement of blood pressure in the office (CAMBO) trialFamily Pract201229376382
  • AlbertiKGMMZimmetPShawJMetabolic syndrome – a new worldwide definition. A consensus statement from the International Diabetes FederationDiabet Med20062346948016681555
  • AkessonAWeismayerCNewbyPKWolkACombined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in femalesArch Intern Med20071672122212717954808
  • YangQCogswellMEFlandersWDTrends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adultsJAMA20123071273128322427615
  • AkessonALarssonSCDiscacciatiAWolkALow-risk diet and lifestyle habits in the primary prevention of myocardial Infarction in males: a population-based prospective cohort studyJ Am Coll Cardiol2014641299130625257629
  • FarkouhMEBodenWEBittnerVRisk factor control for coronary artery disease secondary prevention in large randomized trialsJ Am Coll Cardiol2013611607161523500281
  • TullyLGianosEVaniASuboptimal risk factor control in patients undergoing elective coronary or peripheral percutaneous interventionAm Heart J2014168310316.e325173542
  • Cholesterol Treatment Trialists’ (CTT) CollaborationBaigentCBlackwellLEmbersonJEfficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trialsLancet20103761670168121067804
  • Blood Pressure Lowering Treatment Trialists’ CollaborationSundströmJArimaHWoodwardMBlood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient dataLancet201438459159825131978
  • Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)CatapanoALReinerZDe BackerGESC Committee for Practice Guidelines 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Atherosclerosis2011217Suppl 1S14421723445
  • StroesESThompsonPDCorsiniAEuropean Atherosclerosis Society Consensus Panel. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and ManagementEur Heart J2015361012102225694464
  • ManciniGBJTashakkorAYBakerSDiagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus updateCan J Cardiol201329121553156824267801
  • ZhangHPlutzkyJSkentzosSDiscontinuation of statins in routine care settings: a cohort studyAnn Intern Med201315852653423546564
  • GoldsteinJLBrownMSThe LDL receptorArterioscler Thromb Vasc Biol20092943143819299327
  • MalikSWongNDFranklinSSImpact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adultsCirculation20041101245125015326067
  • CicconeMMScicchitanoPCameliMEndothelial function in pre-diabetes, diabetes and diabetic cardiomyopathy: a reviewJ Diabetes Metab20145110
  • HildrumBMykletunAHoleTMidthjellKDahlAAAge-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 studyBMC Public Health2007722017727697